Global Antibiotic R&D Partnership (GARDP)
Teri Roberts is a Senior Public Health Manager at GARDP, focusing on R&D access development for antibiotic treatments for WHO priority infections impacted by AMR. With a background in immunology, molecular biology, and tuberculosis, Teri has held various roles in different organizations, including as a Senior Innovation Officer at the Elizabeth Glaser Pediatric AIDS Foundation and a Senior Diagnostics Advisor at Médecins sans frontières. Teri's experience spans across HIV, hepatitis C, TB, and immunology, contributing to advancements in diagnostics, biomarkers, and access to innovative technologies in global health.
This person is not in any teams
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org